(Q74239949)
Statements
17q gain in neuroblastoma predicts adverse clinical outcome. U.K. Cancer Cytogenetics Group and the U.K. Children's Cancer Study Group (English)
N Bown
M Lastowska
S Cotterill
S O'Neill
C Ellershaw
P Roberts
I Lewis
A D Pearson
U.K. Cancer Cytogenetics Group and the U.K. Children's Cancer Study Group